KEROS THERAPEUTICS IN
60.24
08-十月-24 14:13:02
15 分钟延时
股票
+0.12
+0.20%
今日范围
59.95 - 61.00
ISIN
N/A
来源
NASDAQ
-
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results
03 11月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
06 9月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
06 9月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results
04 8月 2022 15:01:00 条件 Nasdaq GlobeNewswire
-
18 5月 2022 05:00:00 条件 Nasdaq GlobeNewswire
-
17 5月 2022 15:01:00 条件 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 27th Annual Congress of the European Hematology Association
12 5月 2022 15:01:00 条件 Nasdaq GlobeNewswire
-
Keros Therapeutics Reports First Quarter 2022 Financial Results
05 5月 2022 07:00:03 条件 Nasdaq GlobeNewswire
-
09 3月 2022 15:01:00 条件 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
11 2月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Keros Therapeutics Appoints Christopher Rovaldi as Chief Operating Officer
31 1月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
13 12月 2021 07:00:01 条件 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
22 11月 2021 07:00:01 条件 Nasdaq GlobeNewswire
-
15 11月 2021 07:00:01 条件 Nasdaq GlobeNewswire